Abstract:BACKGROUND:Chronic itch is a highly debilitating symptom that underlies many medical disorders with no universally effective treatments. Although unique neuronal signaling cascades in the sensory ganglia and spinal cord have been shown to critically promote the pathogenesis of chronic itch, the role of skin-associated cells remains poorly understood. OBJECTIVE:We sought to examine the cutaneous mechanisms underlying transient receptor potential vanilloid 4 (TRPV4)-mediated allergic and nonallergic chronic itch. METHODS:Expression of TRPV4 in chronic itch and healthy control skin preparations was examined by using real-time RT-PCR. Trpv4eGFP mice were used to study the expression and function of TRPV4 in the skin by means of immunofluorescence staining, flow cytometry, calcium imaging, and patch-clamp recordings. Genetic and pharmacologic approaches were used to examine the role and underlying mechanisms of TRPV4 in mouse models of dry skin-associated chronic itch and spontaneous scratching associated with squaric acid dibutylester-induced allergic contact dermatitis. RESULTS:TRPV4 is selectively expressed by dermal macrophages and epidermal keratinocytes in mice. Lineage-specific deletion of TRPV4 in macrophages and keratinocytes reduces allergic and nonallergic chronic itch in mice, respectively. Importantly, TRPV4 expression is significantly increased in skin biopsy specimens from patients with chronic idiopathic pruritus in comparison with skin from healthy control subjects. Moreover, TRPV4-dependent chronic itch requires 5-hydroxytryptamine (5-HT) signaling secondary to activation of distinct 5-HT receptors in mice with allergic and those with nonallergic chronic itch conditions. CONCLUSION:Our study reveals previously unrecognized mechanisms by which TRPV4-expressing epithelial and immune cells in the skin critically and dynamically mediate chronic itch and unravels novel targets for therapeutics in the setting of chronic itch.

Inflammatory mediators causing cutaneous chronic itch in some diseases via transient receptor potential channel subfamily V member 1 and subfamily A member 1

Transient receptor potential vanilloid 4-expressing macrophages and keratinocytes contribute differentially to allergic and nonallergic chronic itch.

Sensory TRP channels contribute differentially to skin inflammation and persistent itch

S1P/S1PRs-TRPV4 Axis is a Novel Therapeutic Target for Persistent Pain and Itch in Chronic Dermatitis

Cytokines and Chemokines Modulation of Itch

Sensitization Mechanisms of Chronic Itch

Keratinocyte TLR2 and TLR7 contribute to chronic itch through pruritic cytokines and chemokines in mice

Sensory neuron–expressed TRPC3 mediates acute and chronic itch

TLR3 Deficiency Impairs Spinal Cord Synaptic Transmission, Central Sensitization, and Pruritus in Mice.

The Plasticity of Neuropeptide Y-Y1 Receptor System on Tac2 Neurons Contributes to Mechanical Hyperknesis During Chronic Itch

More Than Scratching the Surface: Recent Progress in Brain Mechanisms Underlying Itch and Scratch

TNF-α/TNFR1 Signaling is Required for the Full Expression of Acute and Chronic Itch in Mice Via Peripheral and Central Mechanisms.

TRPV4-β-catenin axis is a novel therapeutic target for dry skin-induced chronic itch

Site-Specific Transient Receptor Potential Channel Mechanisms and Their Characteristics for Targeted Chronic Itch Treatment

Molecular Mechanisms of Pruritus in Prurigo Nodularis

Common and discrete mechanisms underlying chronic pain and itch: peripheral and central sensitization

Role of Thermotrp Channels in Cutaneous Neurogenic Inflammation and Itch

The Ca2+-Permeable Cation Transient Receptor Potential TRPV3 Channel: An Emerging Pivotal Target for Itch and Skin Diseases

Itch: From mechanism to (novel) therapeutic approaches

Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis

The Ca 2 1-Permeable Cation Transient Receptor Potential TRPV 3 Channel : An Emerging Pivotal Target for Itch and Skin Diseases